Quantitative liver health imaging improves clinical outcomes in colorectal liver metastasis surgery.

Introduction Post-hepatectomy liver failure (PHLF), driven by insufficient volume and quality of the remnant liver following an operation, is a significant clinical problem that is currently underserved by pre-operative assessment methods. Clinical management and a patient's recovery from post-operative liver related complications results in a protracted stay in hospital. Methods 91 patients with colorectal liver metastasis being considered for liver resection were recruited onto the Precision1 trial. The imaging report from an additional non-quantitative multiparametric MRI (mpMRI) scan was examined and used to alter surgical decision making. Patient outcomes were monitored and evaluated against a standard of care comparator dataset blinded to mpMRI scan results. Results Previously undiagnosed liver disease activity or elevated liver fat was detected using mpMRI in 23% of patients, whereas the liver health was unexpectedly good in 7% of patients; this resulted in a change to surgical plan in 29% of cases. The incidence of protracted (over 14 days) length of stay was reduced from 5% to 1% following the introduction of mpMRI reports into surgical decision-making process. Conclusion mpMRI is a safe method to evaluate liver health in patients being considered for liver resection. Surgical decision making can be altered to achieve a safer treatment strategy resulting in shorter hospital stays for patients.

[1]  V. Carapella,et al.  Cardiac impairment in Long Covid 1-year post SARS-CoV-2 infection , 2022, medRxiv.

[2]  R. Banerjee,et al.  Precision medicine for liver tumours with quantitative MRI and whole genome sequencing (Precision1 trial): study protocol for observational cohort study , 2022, BMJ Open.

[3]  J. Fallowfield,et al.  Clinical utility of MRI biomarkers for identifying NASH patients' high risk of progression: A multi-center pooled data and meta-analysis. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  D. Frey,et al.  Patient expectations shape convalescence after major liver surgery - A prospective, randomized study. , 2021, International journal of surgery.

[5]  N. Keeratibharat,et al.  Portal vein embolization: rationale, techniques, outcomes and novel strategies , 2021, Hepatic oncology.

[6]  H. Pommergaard,et al.  Morbidity and mortality after liver surgery for colorectal liver metastases: a cohort study in a high-volume fast-track programme , 2021, BMC Surgery.

[7]  Lucile P. A. Neyton,et al.  Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer , 2020, PloS one.

[8]  S. Neubauer,et al.  Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus , 2020, Abdominal Radiology.

[9]  K. Cusi Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes , 2020, Diabetes Care.

[10]  K. Chok,et al.  Colorectal liver metastases: An update on multidisciplinary approach , 2019, World journal of hepatology.

[11]  Rohit Loomba,et al.  Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials , 2018, Hepatology.

[12]  J. Fütterer,et al.  Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  M. Robson,et al.  Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease , 2014, Journal of hepatology.

[14]  T. Pawlik,et al.  Solitary colorectal liver metastasis: resection determines outcome. , 2006, Archives of surgery.

[15]  K. Lundbaek,et al.  European Association for the study of diabetes , 1969, Diabetologia.

[16]  European Association for the Study of the Liver,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease , 2016, Obesity Facts.

[17]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.